“Branding is a matter of building trust and committing to a level of quality and service. It is an emotional…
*This story will be updated as more details become available* President Trump’s executive order could result in higher US medicines…
Donald Trump is back at it, making big waves in the world of pharmaceuticals. On May 12, 2025, Donald Trump signed…
Data isn’t just an asset—it’s a trust marker. In life sciences, our credibility hinges on who contributes data and whether…
President Trump said recently that the United States will announce a “major” tariff on pharmaceutical imports “very shortly.”
In 2023, Sheldon Ekirch was diagnosed with small fiber neuropathy, which makes her limbs and muscles feel as if they’re…
As a physician, I spend much of my day helping people navigate serious illnesses. But even outside of cancer, some…
When Medicine Transcends the Sterile Clinical Encounter
As the U.S. slashes foreign aid, Europe rewires its model — less charity, more strategic investment.
Despite Record Funding, Clinical Validation Gap Threatens Long-Term Growth of Consumer HealthTech Market
This website uses cookies. Your continued use of the site is subject to the acceptance of these cookies. Please refer to our Privacy Policy for more information.
Read More